Respiratory Syncytial Virus (RSV) Hospitalizations in the Elderly in a Tertiary Care Hospital in Southern Italy as a Useful Proxy for Targeting Vaccine Preventive Strategies
Abstract
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Li, Y.; Wang, X.; Blau, D.M.; Caballero, M.T.; Feikin, D.R.; Gill, C.J.; Madhi, S.A.; Omer, S.B.; Simões, E.A.F.; Campbell, H.; et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: A systematic analysis. Lancet 2022, 399, 2047–2064. [Google Scholar] [CrossRef]
- Nam, H.H.; Ison, M.G. Respiratory syncytial virus infection in adults. BMJ 2019, 366, l5021. [Google Scholar] [CrossRef]
- French, C.E.; McKenzie, B.C.; Coope, C.; Rajanaidu, S.; Paranthaman, K.; Pebody, R.; Nguyen-Van-Tam, J.S.; Noso-RSV Study Group; Higgins, J.P.; Beck, C.R. Risk of nosocomial respiratory syncytial virus infection and effectiveness of control measures to prevent transmission events: A systematic review. Influenza Other Respir. Viruses 2016, 10, 268–290. [Google Scholar] [CrossRef]
- Abu-Raya, B.; Viñeta Paramo, M.; Reicherz, F.; Lavoie, P.M. Why has the epidemiology of RSV changed during the COVID-19 pandemic? EClinicalMedicine 2023, 61, 102089. [Google Scholar] [CrossRef]
- Melgar, M.; Britton, A.; Roper, L.E.; Talbot, H.K.; Long, S.S.; Kotton, C.N.; Havers, F.P. Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices—United States, 2023. Am. J. Transpl. 2023, 23, 1631–1640. [Google Scholar] [CrossRef]
- Savic, M.; Penders, Y.; Shi, T.; Branche, A.; Pirçon, J.Y. Respiratory syncytial virus disease burden in adults aged 60 years and older in high-income countries: A systematic literature review and meta-analysis. Influenza Other Respir. Viruses 2023, 17, e13031. [Google Scholar] [CrossRef]
- Ackerson, B.; Tseng, H.F.; Sy, L.S.; Solano, Z.; Slezak, J.; Luo, Y.; Fischetti, C.A.; Shinde, V. Severe Morbidity and Mortality Associated with Respiratory Syncytial Virus versus Influenza Infection in Hospitalized Older Adults. Clin. Infect. Dis. 2019, 69, 197–203. [Google Scholar] [CrossRef]
- Osei-Yeboah, R.; Spreeuwenberg, P.; Del Riccio, M.; Fischer, T.K.; Egeskov-Cavling, A.M.; Bøås, H.; Van Boven, M.; Wang, X.; Lehtonen, T.; Bangert, M.; et al. Respiratory Syncytial Virus Consortium in Europe (RESCEU) Investigators. Estimation of the Number of Respiratory Syncytial Virus-Associated Hospitalizations in Adults in the European Union. J. Infect. Dis. 2023, 228, 1539–1548. [Google Scholar] [CrossRef]
- Colosia, A.D.; Yang, J.; Hillson, E.; Mauskopf, J.; Copley-Merriman, C.; Shinde, V.; Stoddard, J. The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: A systematic review. PLoS ONE 2017, 12, e0182321. [Google Scholar] [CrossRef]
- Chartrand, C.; Tremblay, N.; Renaud, C.; Papenburg, J. Diagnostic Accuracy of Rapid Antigen Detection Tests for Respiratory Syncytial Virus Infection: Systematic Review and Meta-analysis. J. Clin. Microbiol. 2015, 53, 3738–3749. [Google Scholar] [CrossRef]
- World Health Organization. Respiratory Syncytial Virus Surveillance. Available online: https://www.who.int/teams/global-influenza-programme/global-respiratory-syncytial-virus-surveillance (accessed on 22 May 2024).
- PROMISE European RSV Surveillance Bulletin. Available online: https://imi-promise.eu/surveillance/promise-european-rsv-surveillance-bulletin/ (accessed on 22 May 2024).
- RESCEU Respiratory Syncytial Virus Consortium in EUrope. Available online: https://resc-eu.org/ (accessed on 23 May 2024).
- Istituto Superiore di Sanità. RespiVirNet. Available online: https://respivirnet.iss.it/Default.aspx?ReturnUrl=%2f (accessed on 10 April 2024).
- SITI, SIMIT Joint Paper. Prevenzione Delle Infezioni da Virus Respiratorio Sinciziale Nella Popolazione Italiana. 2024. Available online: https://www.quotidianosanita.it/allegati/allegato1707735493.pdf (accessed on 19 February 2024).
- Rozenbaum, M.H.; Judy, J.; Tran, D.; Yacisin, K.; Kurosky, S.K.; Begier, E. Low Levels of RSV Testing Among Adults Hospitalized for Lower Respiratory Tract Infection in the United States. Infect. Dis. Ther. 2023, 12, 677–685. [Google Scholar] [CrossRef]
- Shi, T.; Denouel, A.; Tietjen, A.K.; Campbell, I.; Moran, E.; Li, X.; Campbell, H.; Demont, C.; Nyawanda, B.O.; Chu, H.Y.; et al. Global Disease Burden Estimates of Respiratory Syncytial Virus-Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis. J. Infect. Dis. 2020, 222, S577–S583. [Google Scholar] [CrossRef]
- Cong, B.; Dighero, I.; Zhang, T.; Chung, A.; Nair, H.; Li, Y. Understanding the age spectrum of respiratory syncytial virus associated hospitalisation and mortality burden based on statistical modelling methods: A systematic analysis. BMC Med. 2023, 21, 224. [Google Scholar] [CrossRef]
- Ivey, K.S.; Edwards, K.M.; Talbot, H.K. Respiratory Syncytial Virus and Associations With Cardiovascular Disease in Adults. J. Am. Coll. Cardiol. 2018, 71, 1574–1583. [Google Scholar] [CrossRef]
- Niekler, P.; Goettler, D.; Liese, J.G.; Streng, A. Hospitalizations due to respiratory syncytial virus (RSV) infections in Germany: A nationwide clinical and direct cost data analysis (2010–2019). Infection 2023. [Google Scholar] [CrossRef]
- Semple, M.G.; Cowell, A.; Dove, W.; Greensill, J.; McNamara, P.S.; Halfhide, C.; Shears, P.; Smyth, R.L.; Hart, C.A. Dual infection of infants by human metapneumovirus and human respiratory syncytial virus is strongly associated with severe bronchiolitis. J. Infect. Dis. 2005, 191, 382–386. [Google Scholar] [CrossRef]
- Goka, E.A.; Vallely, P.J.; Mutton, K.J.; Klapper, P.E. Single, dual and multiple respiratory virus infections and risk of hospitalization and mortality. Epidemiol. Infect. 2015, 143, 37–47. [Google Scholar] [CrossRef]
- Godefroy, R.; Giraud-Gatineau, A.; Jimeno, M.T.; Edouard, S.; Meddeb, L.; Zandotti, C.; Chaudet, H.; Colson, P.; Raoult, D.; Cassir, N. Respiratory Syncytial Virus Infection: Its Propensity for Bacterial Coinfection and Related Mortality in Elderly Adults. Open Forum. Infect. Dis. 2020, 7, ofaa546. [Google Scholar] [CrossRef]
- Del Riccio, M.; Caini, S.; Bonaccorsi, G.; Lorini, C.; Paget, J. Global analysis of respiratory viral circulation and timing of epidemics in the pre-COVID-19 and COVID-19 pandemic eras, based on data from the Global Influenza Surveillance and Response System (GISRS). Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis. 2024, 144, 107052. [Google Scholar] [CrossRef]
- Hamid, S.; Winn, A.; Parikh, R.; Jones, J.M.; McMorrow, M.; Prill, M.M.; Silk, B.J.; Scobie, H.M.; Hall, A.J. Seasonality of Respiratory Syncytial Virus—United States, 2017–2023. MMWR Morb. Mortal. Wkly. Rep. 2023, 72, 355–361. [Google Scholar] [CrossRef]
- Loconsole, D.; Centrone, F.; Rizzo, C.; Caselli, D.; Orlandi, A.; Cardinale, F.; Serio, C.; Giordano, P.; Lassandro, G.; Milella, L.; et al. Out-of-Season Epidemic of Respiratory Syncytial Virus during the COVID-19 Pandemic: The High Burden of Child Hospitalization in an Academic Hospital in Southern Italy in 2021. Children 2022, 9, 848. [Google Scholar] [CrossRef]
N | % | ||
---|---|---|---|
Total | 52 | 100.0% | |
Sex | Female | 21 | 40.4% |
Male | 31 | 59.6% | |
Age, years | 65–70 | 9 | 17.3% |
71–74 | 10 | 19.2% | |
75–79 | 10 | 19.2% | |
>80 | 23 | 44.3% | |
Comorbidities | 21 | 40.4% | |
Respiratory | 15 | 28.8% | |
Cardiovascular | 9 | 17.3% | |
Diabetes | 11 | 21.2% | |
Oncologic | 6 | 11.5% | |
Others | 5 | 9.6% | |
Coinfections | 7 | 13.5% |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Centrone, F.; Loconsole, D.; Marziani, A.; Orlando, V.A.; delle Fontane, A.; Minelli, M.; Chironna, M. Respiratory Syncytial Virus (RSV) Hospitalizations in the Elderly in a Tertiary Care Hospital in Southern Italy as a Useful Proxy for Targeting Vaccine Preventive Strategies. Infect. Dis. Rep. 2024, 16, 491-498. https://doi.org/10.3390/idr16030037
Centrone F, Loconsole D, Marziani A, Orlando VA, delle Fontane A, Minelli M, Chironna M. Respiratory Syncytial Virus (RSV) Hospitalizations in the Elderly in a Tertiary Care Hospital in Southern Italy as a Useful Proxy for Targeting Vaccine Preventive Strategies. Infectious Disease Reports. 2024; 16(3):491-498. https://doi.org/10.3390/idr16030037
Chicago/Turabian StyleCentrone, Francesca, Daniela Loconsole, Alfredo Marziani, Valentina Annachiara Orlando, Arianna delle Fontane, Martina Minelli, and Maria Chironna. 2024. "Respiratory Syncytial Virus (RSV) Hospitalizations in the Elderly in a Tertiary Care Hospital in Southern Italy as a Useful Proxy for Targeting Vaccine Preventive Strategies" Infectious Disease Reports 16, no. 3: 491-498. https://doi.org/10.3390/idr16030037
APA StyleCentrone, F., Loconsole, D., Marziani, A., Orlando, V. A., delle Fontane, A., Minelli, M., & Chironna, M. (2024). Respiratory Syncytial Virus (RSV) Hospitalizations in the Elderly in a Tertiary Care Hospital in Southern Italy as a Useful Proxy for Targeting Vaccine Preventive Strategies. Infectious Disease Reports, 16(3), 491-498. https://doi.org/10.3390/idr16030037